Skip to main content Back to Top

Managing Drug Excipient Toxicities in the wake of COVID-19


Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

In the wake of drug shortages, patients with a high requirement for sedation coupled with an increase in the number of patients who have renal failure due to complications to COVID-19, pharmacists must be ever vigilant on managing patient’s mediation regimens and monitoring for toxicities. With that in mind, we sit down with our content matter experts to talk about managing patients who might be at risk for developing toxicities due to the excipients found in drugs and how pharmacists can play an important role in preventing these adverse events. 


Martha RobertsMartha Roberts received her BS in Pharmacy in 1981 and then her Pharm.D. in 1999 from the University of Rhode Island (URI). One of her major areas of interest is critical care pharmacy and she obtained her BCCCP in 2015. Martha is currently the Pharmacy Department Coordinator at Rhode Island Hospital. She is an Adjunct Clinical Assistant Professor of Pharmacy Practice for the URI. Martha is also a member of ASHP's SAG for Emerging Sciences, SCCM's ICU Liberation Committee, and active participant with the RI Society of Health System Pharmacists.

Vicki BasalygaVicki Basalyga, Pharm.D., BCPS, BCPPS, is the Director for the Section of Clinical Specialists and Scientists. In this role Vicki serves as an information resource and provides guidance to ASHP members regarding science and scientific developments affecting pharmacy practice in health systems. She serves as secretary to the Section executive committee and coordinates activities to accomplish the objectives established by the Section. Additionally, Vicki has assumed the position of Council Secretary for the ASHP's Council on Therapeutics.

Vicki received her Doctor of Pharmacy from Duquesne University and completed an ASHP accredited PGY1 at Children’s National Medical Center in Washington, DC. Vicki is also a Board Certified Pharmacotherapy Specialist and a Board Certified Pediatric Pharmacotherapy Specialist.

Prior to her current position at ASHP, Vicki practiced as critical care pharmacist in both the Cardiac Intensive Care Unit and the Pediatric Intensive Care Unit at Children’s National Medical Center in Washington, DC. Other activities Vicki performed included drafting policies and procedures, co-chairing the Antimicrobial Stewardship Program, creating and drafting order sets for CPOE conversion and precepting residents and students.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.